Patients with pseudophakic eye
Conditions
Interventions
0.1% bromfenac sodium ophthalmic solution
One drop once, twice a day, instilled for 8 days
0.02% fluorometholone ophthalmic suspension
One drop once, twice a day, instilled for 8 days
Sponsors
Department of Ophthalmology, Faculty of Medical Science, University of Fukui
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Patients with the document agreement 2)Pseudophakic eye 3)Patients with the periods of three months or more after the end of the instillation of steroid and NSAIDs ophthalmic solution for post cataract operation
Exclusion criteria
Exclusion criteria: 1)Patients with a history of hypersensitivity against bromfenac and fluorometholone 2)Patients with ocular infections and inflammation (including allergic conjunctivitis and vernal keratoconjunctivitis) 3)Patients who received the ophthalmic surgery (including laser) within three months. 4)Patients with systemic diseases that may affect the efficacy or safety of the test drugs 5)Patients who was judged to be inappropriate as a subject by doctor in charge
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of the cytokine concentration difference (before and 8 days after drug administration) between test drug groups | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of the cytokine concentration between before and 8 days after drug administration in the same group | — |
Countries
Japan
Contacts
Public ContactTakehiro Matsumura
University of Fukui, Faculty of medicine Ophthalmology
Outcome results
None listed